Genaissance Pharmaceuticals (MM) 뉴스 - GNSC | 주식 나스닥

개인 투자자를 위한 전문가급 도구.

Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo

NEW HAVEN, Conn. and TOKYO, Oct. 3 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has entered...

Genaissance Enters Pharmacogenomic Collaboration with Otsuka

NEW HAVEN, Conn. and TOKYO, Sept. 21 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that it has...

Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements

NEW HAVEN, Conn., and MARSEILLE, France, Sept. 12 /PRNewswire-FirstCall/ -- Privately-held Ipsogen SAS and Genaissance Pharmaceuticals, Inc...

Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract

- Increases Presence in EU Ag Genotyping Market - NEW HAVEN, Conn., Aug. 23 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc...

Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract

- Will Address EU Mandate for Sheep-Breeding Programs That Confer Resistance to Scrapie - NEW HAVEN, Conn., Aug. 11 /PRNewswire-FirstCall/...

Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon

Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon NEW HAVEN, Conn. and OSS, Netherlands, July 18...

Clinical Data to Acquire Genaissance Pharmaceuticals

Clinical Data to Acquire Genaissance Pharmaceuticals Combined Company to Deliver Industry-Defining Theranostics NEWTON, Mass., and NEW HAVEN...

Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics

Clinical Data, Inc. (NASDAQ:CLDA) and Genaissance Pharmaceuticals, Inc. (NASDAQ:GNSC) today announced that they have signed an agreement for...

Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner

Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner NEW HAVEN, Conn., June 7 /PRNewswire-FirstCall/...

Genaissance Reports First Quarter 2005 Results

Genaissance Reports First Quarter 2005 Results Company Cites Progress In Key Areas, Including Recent Increase In Cash Reserves NEW HAVEN, Conn...

Genaissance Pharmaceuticals Comments on Stock Activity

Genaissance Pharmaceuticals Comments on Stock Activity NEW HAVEN, Conn., April 28 /PRNewswire-FirstCall/ -- Genaissance Pharmaceuticals, Inc...

Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference

Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference NEW HAVEN, Conn., April 27...

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call NEW HAVEN, Conn., April 26...

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing NEW HAVEN, Conn., April 22 /PRNewswire-FirstCall/...

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing New Haven, Conn., April 22 /PRNewswire-FirstCall/...

DougS. 20 년 전

Thanks. I don't own any. Just curious about the company. I've been waiting for them to take the next step to legitimize their science but it hasn't been forthcoming. Still waiting.

FYI - a prospectus came out that shows deteriorating financials. So be careful! Good luck.

http://www.shareholder.com/GNSC/EdgarDetail.cfm?CompanyID=GNSC&CIK=1110009&FID=1047469-05-15...

👍️0

gator16 20 년 전

I own a lot of GNSC..maybe too much..I keep hearing great things are coming though....guess I will have to wait a while !
98000 shrs at $3.26 groan !!

👍️0

DougS. 20 년 전

Anyone out there follow this company besides me???

👍️0

gator16 20 년 전

Welcome everyone to this new board. This company is the future !!

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Genaissance Pharmaceuticals (MM) (GNSC)

개인 투자자를 위한 전문가급 도구.

GNSC 뉴스

Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo

Genaissance Enters Pharmacogenomic Collaboration with Otsuka

Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements

Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract

Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract

Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon

Clinical Data to Acquire Genaissance Pharmaceuticals

Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics

Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner

Genaissance Reports First Quarter 2005 Results

Genaissance Pharmaceuticals Comments on Stock Activity

Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing

GNSC Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Genaissance Pharmaceuticals (MM) (GNSC) 뉴스

Genaissance Pharmaceuticals (MM) (GNSC)

개인 투자자를 위한 전문가급 도구.

GNSC 뉴스

Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo

Genaissance Enters Pharmacogenomic Collaboration with Otsuka

Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements

Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract

Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract

Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon

Clinical Data to Acquire Genaissance Pharmaceuticals

Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics

Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner

Genaissance Reports First Quarter 2005 Results

Genaissance Pharmaceuticals Comments on Stock Activity

Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing

Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing

GNSC Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거